Eli Lilly (NYSE:LLY) said it is teaming up with pharmacy benefit manager Express Scripts (NSDQ:ESRX) to offer discounts on the US pharma giant’s insulin products for uninsured patients and people with high-deductible insurance plans. The program will begin January 1, 2017 and will cover Lilly’s insulins Humalog, Humulin, and the biologic Basaglar. Lilly said it anticipates the program will provide some patients with a discount as high as 40%.
Insulin drugmakers have been criticized this year for their drug pricing strategies. Sen. Bernie Sanders (I-Vermont) took to Twitter last month and wrote that “People are dying or getting sicker because they can’t afford their insulin, just so Eli Lilly and Novo Nordisk can make outrageous profits.”
Get the full story at our sister site, Drug Delivery Business News.
The post Eli Lilly, Express Scripts offer insulin discount program appeared first on MassDevice.